Abbott Laboratories
Common Stock · USD · XETRA
Price
$86.14
Cap
—
Earnings
—
30d Trend
-8.0%
30% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 45×Macro 0.99 (−1%)=45
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Long-term compounder — quality business with growth runway
BRAIN47'S ASSESSMENT
I rate Abbott Laboratories at 45/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 68/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-5.5%
3 MONTHS
-25.4%
12 MONTHS
-33.7%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder — quality business with growth runway. Quality (68) and Fundamentals (50) are the primary strengths. I note that momentum is the weakest area at 25/100 — this warrants monitoring. Historical volatility is moderate at 30%. I classify this as a defensive holding — stability characteristics and high business quality provide portfolio ballast.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.